Ranibizumab Injection

DRUG9 trials

Conditions

Age-Related Macular DegenerationCentral Retinal Vein Occlusion With Macular EdemaClinically Significant Macular Edema Due to Diabetes MellitusCoats DiseaseDiabetic Macular EdemaDiabetic RetinopathyMacular EdemaMyopic Choroidal Neovascularization

Phase 1

A Prospective Study of Ranibizumab in the Treatment of Postoperative Recurrent Vitreous Haemorrhage of Diabetic Retinopathy

NCT05248334

Tianjin Medical University Eye HospitalDiabetic Retinopathy, Pars Plana Vitrectomy, Postoperative Recurrent Vitreous Hemorrhage +1

Start: 2022-04-10End: 2024-12-30Target: 120Updated: 2022-08-12

Phase 3

Combination of Ranibizumab and Targeted Laser Photocoagulation

Active, not recruitingNCT04444492

University of GiessenCentral Retinal Vein Occlusion With Macular Edema

Start: 2020-08-25End: 2027-11-30Updated: 2026-05-08

Phase 4

Ranibizumab for Myopic Neovascularization

NCT01246089

Instituto de Olhos de GoianiaMyopic Choroidal Neovascularization

Start: 2009-07-31End: 2014-11-30Updated: 2014-01-01

Ranibizumab Plus Indomethacin

CompletedNCT03261635

Università degli Studi di BresciaMacular Edema

Start: 2016-01-07End: 2017-07-25Updated: 2017-08-25

Anti-VEGF Therapy Versus Dexamethasone Implant for DME

NCT03999125

Sudhalkar Eye HospitalClinically Significant Macular Edema Due to Diabetes Mellitus

Start: 2019-06-25End: 2023-06-24Target: 150Updated: 2019-06-26

Unknown Phase

Genetic Polymorphisms in Ranibizumab Treatment in Wet Age-Related Macular Degeneration (AMD)

NCT01676506

Russian Academy of Medical SciencesAge-Related Macular Degeneration

Start: 2011-10-31End: 2015-10-31Target: 300Updated: 2012-08-31

Ranibizumab Versus Dexamethasone Implant in Diabetic Macular Edema

CompletedNCT03385382

G. d'Annunzio UniversityDiabetic Macular Edema

Start: 2016-12-06End: 2017-06-27Updated: 2018-01-02

Evaluation of Retinal and Vascular Features in Coats Disease After Intravitreal Injections of Ranibizumab

CompletedNCT04310631

Federico II UniversityCoats Disease

Start: 2016-01-01End: 2019-12-31Updated: 2020-03-17

OCTA and Polypoidal Choroidal Vasculopathy

CompletedNCT04714242

Federico II UniversityPolypoidal Choroidal Vasculopathy